123 related articles for article (PubMed ID: 33630469)
1. Does Esophagectomy Provide a Survival Advantage to Patients Aged 80 Years or Older? Analyzing 5066 Patients in the National Database of Hospital-based Cancer Registries in Japan.
Motoyama S; Maeda E; Iijima K; Sato Y; Koizumi S; Wakita A; Nagaki Y; Fujita H; Yoneya T; Imai K; Terata K; Minamiya Y; Higashi T
Ann Surg; 2022 Jul; 276(1):e16-e23. PubMed ID: 33630469
[TBL] [Abstract][Full Text] [Related]
2. Esophagectomy performed at institutes certified by the Japan Esophageal Society provide long-term survival advantages to esophageal cancer patients: second report analyzing 4897 cases with propensity score matching.
Motoyama S; Maeda E; Yano M; Yasuda T; Ohira M; Kajiyama Y; Higashi T; Doki Y; Matsubara H
Esophagus; 2020 Apr; 17(2):141-148. PubMed ID: 31939000
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of esophagectomy in patients with thoracic esophageal squamous cell carcinoma receiving definitive radiotherapy or concurrent chemoradiotherapy through intensity-modulated radiation therapy techniques.
Yen YC; Chang JH; Lin WC; Chiou JF; Chang YC; Chang CL; Hsu HL; Chow JM; Yuan KS; Wu ATH; Wu SY
Cancer; 2017 Jun; 123(11):2043-2053. PubMed ID: 28152166
[TBL] [Abstract][Full Text] [Related]
4. Differences in treatment and survival between elderly patients with thoracic esophageal cancer in metropolitan areas and other areas.
Motoyama S; Maeda E; Iijima K; Anbai A; Sato Y; Wakita A; Nagaki Y; Fujita H; Minamiya Y; Higashi T
Cancer Sci; 2021 Oct; 112(10):4281-4291. PubMed ID: 34288283
[TBL] [Abstract][Full Text] [Related]
5. Concurrent chemoradiotherapy with or without surgery for patients with resectable esophageal cancer: An analysis of the National Cancer Data Base.
Naik KB; Liu Y; Goodman M; Gillespie TW; Pickens A; Force SD; Steuer CE; Owonikoko TK; Ramalingam SS; Higgins K; Beitler JJ; Shin DM; Willingham FF; El-Rayes B; Landry JC; Fernandez FG; Saba NF
Cancer; 2017 Sep; 123(18):3476-3485. PubMed ID: 28464264
[TBL] [Abstract][Full Text] [Related]
6. Current status of radiotherapy for patients with thoracic esophageal cancer in Japan, based on the Comprehensive Registry of Esophageal Cancer in Japan from 2009 to 2011 by the Japan Esophageal Society.
Toh Y; Numasaki H; Tachimori Y; Uno T; Jingu K; Nemoto K; Matsubara H
Esophagus; 2020 Jan; 17(1):25-32. PubMed ID: 31473871
[TBL] [Abstract][Full Text] [Related]
7. Appropriateness of the institute certification system for esophageal surgeries by the Japan Esophageal Society: evaluation of survival outcomes using data from the National Database of Hospital-Based Cancer Registries in Japan.
Motoyama S; Maeda E; Yano M; Yasuda T; Ohira M; Doki Y; Toh Y; Higashi T; Matsubara H;
Esophagus; 2019 Jan; 16(1):114-121. PubMed ID: 30324431
[TBL] [Abstract][Full Text] [Related]
8. Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III esophageal cancer patients.
Liao Z; Zhang Z; Jin J; Ajani JA; Swisher SG; Stevens CW; Ho L; Smythe R; Vaporciyan AA; Putnam JB; Walsh GL; Roth JA; Yao JC; Allen PK; Cox JD; Komaki R
Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1484-93. PubMed ID: 15590179
[TBL] [Abstract][Full Text] [Related]
9. Clinical T2N0M0 Esophageal Cancer-Is Treatment Pathway Associated With Overall Survival?
Ma W; Nuckles B; Frank K; Young KA; Hoffman RL; Blansfield JA
J Surg Res; 2023 Mar; 283():205-216. PubMed ID: 36410237
[TBL] [Abstract][Full Text] [Related]
10. The effect of surgery plus chemoradiotherapy on survival of elderly patients with stage Ⅱ-Ⅲ esophageal cancer: a SEER-based demographic analysis.
Lv H; Chao C; Wang B; Wang Z; Qian Y; Zhang X
Cancer Med; 2021 Dec; 10(23):8483-8496. PubMed ID: 34800005
[TBL] [Abstract][Full Text] [Related]
11. Clinical outcomes of elderly patients (≥70 years) with resectable esophageal squamous cell carcinoma who underwent esophagectomy or chemoradiotherapy: A retrospective analysis from a single cancer institute.
Jing W; Guo H; Kong L; Zhang Y; Wang H; An C; Zhu H; Yu J
Medicine (Baltimore); 2016 Dec; 95(50):e5630. PubMed ID: 27977606
[TBL] [Abstract][Full Text] [Related]
12. Impact of Age on Long-Term Survival in Patients with Esophageal Cancer Who Underwent Transthoracic Esophagectomy.
Motoori M; Ito Y; Miyashiro I; Sugimura K; Miyata H; Omori T; Fujiwara Y; Yano M
Oncology; 2019; 97(3):149-154. PubMed ID: 31195394
[TBL] [Abstract][Full Text] [Related]
13. Comparison Between Esophagectomy and Definitive Chemoradiotherapy in Patients With Esophageal Cancer.
Wang BY; Hung WH; Wu SC; Chen HC; Huang CL; Lin CH; Chen HS
Ann Thorac Surg; 2019 Apr; 107(4):1060-1067. PubMed ID: 30571951
[TBL] [Abstract][Full Text] [Related]
14. Salvage Esophagectomy After Definitive Chemoradiotherapy for Patients with Esophageal Squamous Cell Carcinoma: Who Really Benefits from this High-Risk Surgery?
Watanabe M; Mine S; Nishida K; Yamada K; Shigaki H; Matsumoto A; Sano T
Ann Surg Oncol; 2015 Dec; 22(13):4438-44. PubMed ID: 25862582
[TBL] [Abstract][Full Text] [Related]
15. Impact of Age on Surgical Outcomes for Locally Advanced Esophageal Cancer.
Farrow NE; Raman V; Jawitz OK; Voigt SL; Tong BC; Harpole DH; D'Amico TA
Ann Thorac Surg; 2021 Mar; 111(3):996-1003. PubMed ID: 32853569
[TBL] [Abstract][Full Text] [Related]
16. Comparison between surgery and definitive chemoradiotherapy for patients with resectable esophageal squamous cell carcinoma: a propensity score analysis.
Nomura M; Oze I; Kodaira T; Abe T; Komori A; Narita Y; Masuishi T; Taniguchi H; Kadowaki S; Ura T; Andoh M; Tachibana H; Uemura N; Tajika M; Niwa Y; Muto M; Muro K
Int J Clin Oncol; 2016 Oct; 21(5):890-898. PubMed ID: 26980212
[TBL] [Abstract][Full Text] [Related]
17. Comparison of neoadjuvant chemotherapy versus upfront surgery with or without chemotherapy for patients with clinical stage III esophageal squamous cell carcinoma.
Matsuda S; Tsubosa Y; Sato H; Takebayashi K; Kawamorita K; Mori K; Niihara M; Tsushima T; Yokota T; Onozawa Y; Yasui H; Takeuchi H; Kitagawa Y
Dis Esophagus; 2017 Feb; 30(2):1-8. PubMed ID: 26919154
[TBL] [Abstract][Full Text] [Related]
18. Treatment Modalities for Esophageal Adenocarcinoma in the United States: Trends and Survival Outcomes.
Di Corpo M; Schlottmann F; Strassle PD; Nurczyk K; Patti MG
J Laparoendosc Adv Surg Tech A; 2019 Aug; 29(8):989-994. PubMed ID: 31246532
[No Abstract] [Full Text] [Related]
19. Impact of Lymph Node Yield on Overall Survival in Patients Treated With Neoadjuvant Chemoradiotherapy Followed by Esophagectomy for Cancer: A Population-based Cohort Study in the Netherlands.
Visser E; van Rossum PSN; Ruurda JP; van Hillegersberg R
Ann Surg; 2017 Nov; 266(5):863-869. PubMed ID: 28742691
[TBL] [Abstract][Full Text] [Related]
20. [Predictive value of log odds of positive lymph nodes for the prognosis of patients with node-negative squamous cell carcinoma of the thoracic esophagus after radical esophagectomy].
Yang M; Zhang H; Huo X; Chen C; Yu Z
Zhonghua Wei Chang Wai Ke Za Zhi; 2016 May; 19(5):535-9. PubMed ID: 27215521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
